The data will be presented during an oral session titled, "Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects," taking place today from 2:45 p.m. - 4:15 p.m. at the 56th American Society of Hematology Annual Meeting in San Francisco. Chronic GVHD is a common and often fatal graft-mediated complication following allogeneic stem cell transplantation.
http://ift.tt/1IrSILF
http://ift.tt/1IrSILF
No comments:
Post a Comment